Gene Therapy

There are a lot of things that need to happen for this to mature as an important part of health care. I just have no doubt it's going to happen. The the areas that are challenging for us right now are also some of the aras of great unmet need. In onchology, we really haven't cracked the technological challenge of finding a seltherapy that is deeply effective against solid tumors. And i think almost any area where you start to see valuations of bite s exceed the true value that tho bite companies have should be concerned about.